BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30606107)

  • 1. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells.
    Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Macejová M; Košuth J; Zulli A; Debeljak N; Hudler P; Jašek K; Kašubová I; Kubatka P; Solár P
    BMC Genet; 2019 Jan; 20(1):1. PubMed ID: 30606107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and processing of erythropoietin receptor transcripts in brain.
    Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
    Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody.
    Fecková B; Kimáková P; Ilkovičová L; Szentpéteriová E; Debeljak N; Solárová Z; Sačková V; Šemeláková M; Bhide M; Solár P
    Oncol Lett; 2016 Aug; 12(2):1575-1580. PubMed ID: 27446474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of expression and function of erythropoietin receptors in the kidney.
    Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
    Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein.
    Winkelmann JC; Ward J; Mayeux P; Lacombe C; Schimmenti L; Jenkins RB
    Blood; 1995 Jan; 85(1):179-85. PubMed ID: 7803793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of erythropoietin receptor splice variants in human cancer.
    Arcasoy MO; Jiang X; Haroon ZA
    Biochem Biophys Res Commun; 2003 Aug; 307(4):999-1007. PubMed ID: 12878211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
    Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
    Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
    Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
    Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.
    Pharr PN; Hankins D; Hofbauer A; Lodish HF; Longmore GD
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):938-42. PubMed ID: 7679218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of functional EpoR expression in human tumor cell lines.
    Swift S; Ellison AR; Kassner P; McCaffery I; Rossi J; Sinclair AM; Begley CG; Elliott S
    Blood; 2010 May; 115(21):4254-63. PubMed ID: 20124514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells.
    Jeong JY; Feldman L; Solar P; Szenajch J; Sytkowski AJ
    Int J Cancer; 2008 Jan; 122(2):274-80. PubMed ID: 17893874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
    Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
    Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
    J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
    Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
    Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
    Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
    Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
    Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epo receptors are not detectable in primary human tumor tissue samples.
    Elliott S; Swift S; Busse L; Scully S; Van G; Rossi J; Johnson C
    PLoS One; 2013; 8(7):e68083. PubMed ID: 23861852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera.
    Chiba S; Takahashi T; Takeshita K; Minowada J; Yazaki Y; Ruddle FH; Hirai H
    Blood; 1997 Jul; 90(1):97-104. PubMed ID: 9207443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery.
    Caprara C; Britschgi C; Samardzija M; Grimm C
    Mol Vis; 2014; 20():307-24. PubMed ID: 24644405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
    Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.